Log in to save to my catalogue
Log in to save to my catalogue

4CPS-113 Drug cost saving resulting from metastatic melanoma clinical trials

| Ask | Become a Library member

4CPS-113 Drug cost saving resulting from metastatic melanoma clinical trials

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2190012465

4CPS-113 Drug cost saving resulting from metastatic melanoma clinical trials

About this item

Full title

4CPS-113 Drug cost saving resulting from metastatic melanoma clinical trials

Author / Creator

García Moreno, FJ , González-Haba Peña, E , Sánchez Fresneda, MN , García Martín, E , García Sánchez, S , Marzal Alfaro, B , Collado Borrell, R , Mur Mur, A , Herranz Alonso, A and Sanjurjo Sáez, M

Publisher

London: BMJ Publishing Group LTD

Journal title

European journal of hospital pharmacy. Science and practice, 2019-03, Vol.26 (Suppl 1), p.A121-A121

Language

English

Formats

Articles

Publication information

Publisher

London: BMJ Publishing Group LTD

Subjects

More information

Scope and Contents

Contents

BackgroundThe development of checkpoint inhibitors-based immunotherapy has completely changed the therapeutic approach of metastatic melanoma (MM). In parallel, research activity concerning this tumour continues at a very high level through a large number of active industry-funded clinical trials.PurposeTo estimate the cost saving in MM therapy att...

Alternative Titles

Full title

4CPS-113 Drug cost saving resulting from metastatic melanoma clinical trials

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2190012465

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2190012465

Other Identifiers

ISSN

2047-9956

E-ISSN

2047-9964

DOI

10.1136/ejhpharm-2019-eahpconf.262

How to access this item

Log in as a Library member

Full text available

View in old catalogue

Connecting people and collections